In the article titled “Intensive Care and Anesthesia Management for HARPOON Beating Heart Mitral Valve Repair”, published on pages 321-326, Issue 3, Volume 23 of Annals of Cardiac Anaesthesia,[1] the below statement was incorrectly written on page 321, 35th line of the last paragraph under Introduction heading:”The early results of both an initial feasibility study[7] and a further trial toward gaining CE approval (the “Tracer Trial”),[8] have involved a total of 43 patients in six centers in Europe, with a reported procedural success rate of 95% (41 out of 43 patients), and of those patients with a HARPOON Beating Heart MVRS repair, freedom from moderate magnetic resonance (MR) or worse at 6 months of 89%.”The correct statement should read as:”The early results of both an initial feasibility study[7] and a further trial toward gaining CE approval (the “Tracer Trial”),[8] have involved a total of 41 patients in six centers in Europe, with a reported procedural success rate of 95% (39 out of 41 patients), and of those patients with a HARPOON Beating Heart MVRS repair, freedom from moderate mitral regurgitation (MR) or worse at 6 months of 83%..”